Do you need a license to sell research peptides?

"Do I need a license to sell peptides?" is one of the most common questions from new research resellers. The honest answer is that the license question depends almost entirely on two things: what the product is, and what the seller represents it to be for. This guide separates the registrations that almost every seller needs from the regulatory regimes that apply only in specific cases, and explains why the research-use-only framing matters.

Registrations most research peptide sellers need

The SBA's licensing guide notes that requirements differ by industry, state and locality, so check your state and city as well as federal rules. Suppliers such as WholesalePeptide.us ask for these documents when you open a wholesale account.

Why intended use decides which rules apply

Federal drug law turns on intended use. The Federal Food, Drug, and Cosmetic Act defines a drug to include articles intended for use in the diagnosis, mitigation or prevention of disease, or intended to affect the structure or any function of the body (21 U.S.C. 321(g)(1)). FDA's regulation at 21 CFR 201.128 explains that intended use is shown by "labeling claims, advertising matter, or oral or written statements" and by "the circumstances surrounding the distribution of the article."

If a peptide is sold for laboratory research and every part of the business is consistent with that, it is handled as a research chemical. If the same peptide is promoted or sold for use in people, it is a drug in the eyes of the law, regardless of any disclaimer. Our explainer on research-use-only peptides covers this in more depth.

Federal rules that apply when a product is a drug

• New drug approval (21 U.S.C. 355): a new drug may not be introduced into interstate commerce without an approved application.
• Prohibited acts (21 U.S.C. 331): introducing an adulterated, misbranded or unapproved new drug into interstate commerce is prohibited.
• Manufacturing controls: drug manufacturers must follow FDA's current good manufacturing practice (CGMP) regulations.
• Supply-chain rules: wholesale distribution of finished drug products is subject to the Drug Supply Chain Security Act and state wholesale-distributor licensing.
• Compounding (21 U.S.C. 353a): pharmacy compounding has its own conditions, including limits on which bulk drug substances may be used.

None of these provide a license that lets a research-materials business sell peptides for human use. A seller that wants to supply drugs needs to be a drug business, with the approvals, registrations and controls that come with it.

Controlled substances

Most research peptides are not controlled substances. Any compound that is listed on the federal schedules of controlled substances (21 U.S.C. 812) or on a state schedule requires DEA and state registration to handle, regardless of research use. Check each compound you plan to carry against current federal and state schedules before listing it.

State requirements

States can add requirements on top of federal law, including wholesale-distributor licensing for drugs, rules on specific substances, and consumer-protection rules for online sales. Requirements differ from state to state. A reseller that ships nationwide should map the states it sells into and confirm with counsel whether any of them regulate the compounds it carries.

Recent regulatory context (2026)

On October 30, 2026, the Department of Health and Human Services published FR Doc. 2026-22192 in the Federal Register, announcing a draft "Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances." Under the draft policy, HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities or licensed physicians compounding with the peptide bulk drug substances listed in the policy's appendix, while FDA develops the 503A bulks list through rulemaking. The notice opened a two-week comment period on Docket No. HHS-OASH-2026-0496 and states that the policy is not binding and may be revisited.

This policy applies to licensed pharmacy compounding. It does not license research-materials sellers, and it does not permit research-use-only products to be sold for human use. FDA also publishes the list of bulk drug substances nominated for 503A compounding and a separate list of substances it has identified as presenting significant safety risks; both are cited in our research-use-only explainer. FDA posts its warning letters publicly; reviewing letters issued to peptide sellers is the most direct way to see which labeling and marketing practices draw enforcement.

A compliance checklist for research peptide sellers

How WholesalePeptide.us handles this

Labeling, records and selling to institutions

Good records are the practical side of compliance. A seller that can show which lot went to which customer, with the COA and the customer's signed research-use-only acknowledgment, is in a far better position than one that cannot. Institutional buyers such as universities and contract research organizations often require these records anyway, together with a W-9, a safety data sheet for each compound and written terms.

• Keep a customer file with business verification and the signed research-use-only acknowledgment.
• Record the lot code shipped on every order line and keep the matching COA.
• Keep a safety data sheet for each compound and supply it on request.
• Retain invoices, packing slips and correspondence for the period your accountant and counsel recommend.
• Review product pages, emails and social content periodically for any language that implies use in people or animals.

These records also make it easier to answer a regulator, a payment processor or a shipping carrier that asks how the business operates. Many payment processors and carriers have their own policies on research chemicals and will ask for the same documentation.

WholesalePeptide.us sells only research-use-only materials to laboratories, universities, biotech groups, research resellers and distributors. Every account accepts research-use-only terms, every label carries the research-use-only statement, and A lot-specific Certificate of Analysis is published before the lot ships. We decline orders that indicate personal use and close accounts that represent our products for human or veterinary use. Resellers can read what we require on our resellers and brands page and in our research use only policy. For step-by-step setup, see how to become a peptide reseller, and for pricing on wholesale peptides, see the price list.